Maravai Lifesciences Holdings (MRVI) Change in Cash (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Change in Cash of -$51.0 million in Q1 2026, down 91.01% quarter-over-quarter from -$26.7 million in Q4 2025, and down 36.48% on a YoY basis from -$80.2 million in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Change in Cash (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Change in Cash history runs 7 years deep, the most recent figure standing at -$51.0 million for Q1 2026.
- In Q1 2026, Change in Cash fell 36.48% year-over-year to -$51.0 million; the TTM figure through Mar 2026 stood at -$119.1 million (up 56.94% YoY), while the FY2025 annual figure was -$105.5 million, up 58.22% from the prior year.
- Change in Cash was -$51.0 million for Q1 2026 at Maravai Lifesciences Holdings, down from -$26.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $119.2 million in Q2 2022 to a low of -$255.8 million in Q4 2024.
- Historically, Change in Cash has averaged -$22.7 million across 5 years, with a median of -$13.3 million in 2024.
- Biggest YoY gain for Change in Cash was 973.2% in 2024; the steepest drop was 5408.46% in 2024.
- A 5-year view of Change in Cash shows it stood at $14.7 million in 2022, then plunged by 131.6% to -$4.6 million in 2023, then plunged by 5408.46% to -$255.8 million in 2024, then surged by 89.57% to -$26.7 million in 2025, then slumped by 91.01% to -$51.0 million in 2026.
- The last three Change in Cash figures came in at -$51.0 million (Q1 2026), -$26.7 million (Q4 2025), and -$26.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -45.97 Mn |
| 10 | Maravai Lifesciences Holdings | 727.74 Mn | 719.33 Mn | 33.70 Mn | -50.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.97 Mn |
| Dec 31, 2025 | -26.68 Mn |
| Sep 30, 2025 | -26.33 Mn |
| Jun 30, 2025 | -15.15 Mn |
| Mar 31, 2025 | -37.35 Mn |
| Dec 31, 2024 | -255.76 Mn |
| Sep 30, 2024 | 4.99 Mn |
| Jun 30, 2024 | 11.48 Mn |
| Mar 31, 2024 | -13.27 Mn |
| Dec 31, 2023 | -4.64 Mn |
| Sep 30, 2023 | -571,000.00 |
| Jun 30, 2023 | -48.10 Mn |
| Mar 31, 2023 | -3.87 Mn |
| Dec 31, 2022 | 14.69 Mn |
| Sep 30, 2022 | 66.77 Mn |
| Jun 30, 2022 | 119.21 Mn |
| Mar 31, 2022 | -119.80 Mn |
| Dec 31, 2021 | 3.37 Mn |
| Sep 30, 2021 | 172.94 Mn |
| Jun 30, 2021 | 127.29 Mn |